BioAge Labs, Inc.
BIOA
$4.39
$0.163.78%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 6.14M | 4.73M | 4.80M | 3.49M | 3.51M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 25.36M | 24.75M | 15.27M | 12.81M | 13.60M |
| Operating Income | -25.36M | -24.75M | -15.27M | -12.81M | -13.60M |
| Income Before Tax | -21.13M | -23.41M | -13.58M | -12.99M | -20.96M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -21.13M | -23.41M | -13.58M | -12.99M | -20.96M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -21.13M | -23.41M | -13.58M | -12.99M | -20.96M |
| EBIT | -25.36M | -24.75M | -15.27M | -12.81M | -13.60M |
| EBITDA | -25.32M | -24.71M | -15.22M | -12.78M | -13.56M |
| EPS Basic | -0.59 | -6.70 | -7.94 | -7.76 | -12.53 |
| Normalized Basic EPS | -0.37 | -4.19 | -4.96 | -4.76 | -4.06 |
| EPS Diluted | -0.59 | -6.70 | -7.94 | -7.76 | -12.53 |
| Normalized Diluted EPS | -0.37 | -4.19 | -4.96 | -4.76 | -4.06 |
| Average Basic Shares Outstanding | 36.01M | 3.49M | 1.71M | 1.67M | 1.67M |
| Average Diluted Shares Outstanding | 36.01M | 3.49M | 1.71M | 1.67M | 1.67M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |